Abbott 17-March-99 In vitro diagnostic products 2. Failure to document all activities required by 21 CFR 820.100(b) as they relate to corrective and preventive action. For example: a. There is no documentation of the management review and approval of the decision not to send a customer communication to alert Axsym instrument users of a system...Read More